TechSci Healthcare Industry Report

Rising prevalence of chronic conditions is expected to drive the growth of India clinical trials market during the forecast period. According to TechSci Research report,  “ India  Clinical Trials Market  By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Treatment Studies, Observational, Expanded Access), By Indication (Autoimmune, Blood Disorders, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, Others), By End User (Hospital, Laboratories, Clinics), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India clinical trials market is expected to grow at a steady rate during the forecast period. Increasing demand for clinical trials in the country is projected to act as major market driving factor. Moreover, growing number of biologics coupled with increasing need for personalized medicines are further expected to fuel the market growth through FY2026. Furthermore, huge and diverse population of I...

  Rising prevalence of chronic conditions is expected to drive the growth of India clinical trials market during the forecast period. According to TechSci Research report,  “ India  Clinical Trials Market  By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Treatment Studies, Observational, Expanded Access), By Indication (Autoimmune, Blood Disorders, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, Others), By End User (Hospital, Laboratories, Clinics), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India clinical trials market is expected to grow at a steady rate during the forecast period. Increasing demand for clinical trials in the country is projected to act as major market driving factor. Moreover, growing number of biologics coupled with increasing need for personalized medicines are further expected to fuel the market growth through FY2026. Furthermore, huge and diverse populati...